OCC-1 Synthetic Peptide, PEP-0790, from Invitrogen.
OCC-1 (Overexpressed in colon carcinoma-1) was initially identified as a novel human cDNA overexpressed in a colon carcinoma cell line. Elevated levels of OCC-1 mRNA were observed in three of eight colon carcinomas, suggesting that OCC-1 may be a hallmark of only a subset of colon carcinomas. It is highly expressed in skeletal muscle, kidney, placenta, and pancreas tissues, with low to no expression in heart, brain, lung and liver tissues. At least two different OCC-1 mRNA species are known to exist.
Caractéristiques techniques
| Marque | Invitrogen |
| Réf. B-LABO | BL-RE-175710 |
| Réf. fabricant | 15369010 |
| Gene ID (Entrez) | 387882 |
|---|
| Espèces | Human |
|---|
| Méthode de purification | purified |
|---|
| Numéro d’adhésion | Q8TAD7 |
|---|
| Nom usuel | Human OCC1 |
|---|
| Concentration | 200 μg/mL |
|---|
| Contenu et stockage | -20°C |
|---|
| Format | Liquid |
|---|
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
|---|
| À utiliser avec (application) | Blocking Assay, Control |
|---|
| Symbole de gène(s) | C12orf75 |
|---|
| Lyophilisé | No |
|---|
| Conservateur | 0.02% sodium azide |
|---|
| Type de produit | Peptide |
|---|
| Quantité | 50 μg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Tampon de stockage | PBS |
Une question, une configuration particulière ?
Contactez-nous pour un devis.